1Sersté T,Melot C,Francoz C,Durand F,Rautou PE,Valla D,Moreau R,Lebrec D.Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.Hepatology,2010;52:1017-1022. 被引量：1
2Wong F,Watson H,Gerbes A,Vilstrup H,Badalamenti S,Bernardi M,Ginès P.Satavaptan for the management of ascites in cirrhosis:efficacy and safety across the spectrum of ascites severity.Gut,2012;61:108-116. 被引量：1
